Donald A. Denkhaus, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 25,000 shares at $1.91 ($48K) on 2018-12-27, disclosed to the SEC on 2018-12-28.
Open-market purchase of $48k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CPRX | BUY | 2018-12-17 | $149K | — | Filing → |
| CPRX | BUY | 2018-06-11 | $68K | — | Filing → |
| CPRX | BUY | 2018-05-31 | $75K | — | Filing → |